Entering text into the input field will update the search result below

Healthcare ratings roundup - new coverage

  • Achillion Pharmaceuticals (NASDAQ:ACHN) initiated with Sell rating and $4 (54% downside risk) price target by Chardan Capital.
  • Rigel Pharmaceuticals (NASDAQ:RIGL) initiated with Buy rating and $6 (182% upside) price target by H.C. Wainwright.
  • Aviragen Therapeutics (AVIR) initiated with Buy rating and $5 (178% upside) price target by H.C. Wainwright.
  • Incyte (NASDAQ:INCY) initiated with Outperform rating by Berenberg.
  • TearLab (NASDAQ:TEAR) initiated with Buy rating and $2 (167% upside) price target by Rodman & Renshaw.
  • AstraZeneca (NYSE:AZN) initiated with Hold rating by Argus Research.
  • Spark Therapeutics (NASDAQ:ONCE) initiated with Outperform rating and $70 (32% upside) price target by RBC Capital.
  • Akari Therapeutics (NASDAQ:AKTX) initiated with Sell rating and $5 (55% downside risk) price target by Chardan Capital.

Recommended For You

About AAQL Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AAQL--
Antiaging Quantum Living Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.